Cargando…
Perftoran( ® ) Inhibits Hypoxia-Associated Resistance in Lung Cancer Cells to Carboplatin
Perftoran(®) (perfluorodecalin) is an oxygen carrier, and carboplatin is a common chemotherapy drug used worldwide for lung cancer treatment. Hypoxia is one of the factors that induce resistance of lung cancer cells to carboplatin. This study explored the role of Perftoran(®), as an oxygen carrier,...
Autores principales: | Gamal-Eldeen, Amira M., Alrehaili, Amani A., Alharthi, Afaf, Raafat, Bassem M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987772/ https://www.ncbi.nlm.nih.gov/pubmed/35401227 http://dx.doi.org/10.3389/fphar.2022.860898 |
Ejemplares similares
-
Effect of Combined Perftoran and Indocyanine Green-Photodynamic Therapy on HypoxamiRs and OncomiRs in Lung Cancer Cells
por: Gamal-Eldeen, Amira M., et al.
Publicado: (2022) -
Phthalimide Analogs Enhance Genotoxicity of Cyclophosphamide and Inhibit Its Associated Hypoxia
por: Gamal-Eldeen, Amira M., et al.
Publicado: (2022) -
Anti-hypoxic Effect of Polysaccharide Extract of Brown Seaweed Sargassum dentifolium in Tongue Squamous Cell Carcinoma
por: Gamal-Eldeen, Amira M., et al.
Publicado: (2022) -
Cerebral Microvascular and Systemic Effects Following Intravenous Administration of the Perfluorocarbon Emulsion Perftoran
por: Abutarboush, Rania, et al.
Publicado: (2016) -
Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)